Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy.

Trial Profile

Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 05 May 2017

At a glance

  • Drugs Cixutumumab (Primary)
  • Indications Mesothelioma
  • Focus Pharmacogenomic; Therapeutic Use
  • Most Recent Events

    • 27 Apr 2017 Planned End Date changed from 1 Jan 2017 to 1 Jan 2018.
    • 31 Aug 2016 Planned End Date changed from 1 Jun 2016 to 1 Jan 2017.
    • 04 Aug 2015 Planned End Date changed from 1 Jul 2013 to 1 Jun 2016 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top